-
Unplugging to Reconnect The Art of Digital Detox for a Healthier Lifestyle
In today’s fast-paced and technology-driven world, it’s easy to get caught up in the constant buzz of notifications, social media updates, and endless scrolling. Our smartphones and other digital devices have become an integral part of our daily lives, and it’s hard to imagine a day without them. But have you ever stopped to think…
-
California Civil Rights Department Unveils New Proposed Regulations on Employers’ Use of AI and Automated Systems
The California Civil Rights Department (CRD) has released new proposed regulations regarding employers’ use of artificial intelligence (AI) and automated decision-making systems that would affirm that the use of such technology in a way that discriminates against employees and job applicants based on protected characteristics is a substantive violation of California law….By: Ogletree, Deakins, Nash,…
-
Bipartisan Group Introduces Legislation to Control Exports of AI Systems
Overseas Critical Exports (ENFORCE) Act—a bill to expand the authority of the Bureau of Industry and Security (BIS) to control the export of artificial intelligence (AI) systems and other emerging technology with national security implications….By: Fenwick & West LLP
-
Minnesota Enacts the Latest State Privacy Law – HF 4757 / SF 4782
On May 24, Minnesota Governor Tim Walz (D) signed the Minnesota Consumer Data Privacy Act (MCDPA) into law. The MCDPA largely aligns with previous state consumer privacy laws, but it introduces some significant and novel variations. These distinctions include requiring controllers to maintain a data inventory, to document and maintain a description of policies and…
-
FDA Launches Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program
On May 31, 2024, the FDA announced initiation of the Support for Clinical Trials Advancing Rare Disease Therapeutics (“START”) pilot program. The START program, led by the Center for Biologics Evaluation and Research (“CBER”) and Center for Drug Evaluation and Research (“CDER”), was designed to “help further accelerate the development of novel drug and biological…
-
Changes Ahead: FedRAMP’s Roadmap To The Future
There were no signs of slowing down as FedRAMP announced its ambitious plan to make significant changes over the next two years. During a recent public forum, FedRAMP discussed the planned changes to its program to accelerate FedRAMP authorization and ease the way for cloud service providers (CSPs) to work with the government while maintaining…